|
Volumn 451, Issue 7181, 2008, Pages 914-918
|
Triggers, targets and treatments for thrombosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ANTIVITAMIN K;
APIXABAN;
APTAMER;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
CLOPIDOGREL;
DABIGATRAN;
DESULFATOHIRUDIN;
E 5555;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
FONDAPARINUX;
HEPARIN;
IDRAPARINUX;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
PACLITAXEL;
PRASUGREL;
PROSTAGLANDIN SYNTHASE INHIBITOR;
RAPAMYCIN;
RIVAROXABAN;
ROFECOXIB;
SCH 530348;
UNCLASSIFIED DRUG;
VALDECOXIB;
WARFARIN;
BLOOD;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
DEVELOPING WORLD;
DRUG;
ACUTE CORONARY SYNDROME;
ARTERIAL CIRCULATION;
ARTERY THROMBOSIS;
BLEEDING;
BLOOD;
BLOOD VESSEL WALL;
CORONARY ARTERY DISEASE;
DEATH;
DRUG ELUTING STENT;
HEART INFARCTION;
HEPARIN INDUCED THROMBOCYTOPENIA;
HUMAN;
MORTALITY;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
STOMACH ULCER;
STROKE;
THROMBOSIS;
UNSTABLE ANGINA PECTORIS;
VENOUS CIRCULATION;
VENOUS THROMBOEMBOLISM;
|
EID: 39749109478
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature06797 Document Type: Review |
Times cited : (926)
|
References (59)
|